Cindy H. Chau

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 33 papers. Top paper: “Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models”.

Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0228

N/A

0.818DataRank · unranked

20 citations

Cindy H. Chau, Jonathan D. Strope, Alwin D. R. Huitema, Tristan M. Sissung, Douglas K. Price +2 more

A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide

The Oncologist(2022)10.1093/oncolo/oyac100

N/A

0.790DataRank · unranked

24 citations

Fatima Karzai, Marijo Bilušić, Lisa M. Cordes, Cindy H. Chau, Cody J. Peer +8 more

TMPRSS2: Potential Biomarker for COVID‐19 Outcomes

The Journal of Clinical Pharmacology(2020)10.1002/jcph.1641

N/A

0DataRank · unranked

93 citations

Cindy H. Chau, William D. Figg, Jonathan D. Strope

Are sex discordant outcomes in COVID-19 related to sex hormones?

Seminars in Oncology(2020)10.1053/j.seminoncol.2020.06.002

N/A

0DataRank · unranked

60 citations

Cindy H. Chau, William D. Figg, Jonathan D. Strope

Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs

Molecules(2020)10.3390/molecules25235683

N/A

0DataRank · unranked

23 citations

Shaunna Beedie, Cindy H. Chau, Matthew K. Collins, Suzana Markolovic, Weiming Luo +8 more

On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs

Biochemical and Biophysical Research Communications(2020)10.1016/j.bbrc.2020.11.117

N/A

0DataRank · unranked

18 citations

Samuel Maiwald, Christian Steinebach, Matthew K. Collins, Jonathan D. Strope, Cindy H. Chau +4 more

Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2019.11.002

N/A

0DataRank · unranked

17 citations

Keith T. Schmidt, Fatima Karzai, Cody J. Peer, Lisa M. Cordes, Cindy H. Chau +8 more

Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs

The FASEB Journal(2020)10.1096/fj.201903060rr

N/A

0DataRank · unranked

28 citations

Phoebe Huang, Emily Harris, Jonathan D. Strope, Christopher B. Mahony, Cindy H. Chau +3 more

Resistance to second-generation androgen receptor antagonists in prostate cancer

Nature Reviews Urology(2021)10.1038/s41585-021-00438-4

N/A

0DataRank · unranked

128 citations

Alwin D. R. Huitema, Cindy H. Chau, William D. Figg, Keith T. Schmidt

Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management

Cancers(2021)10.3390/cancers13092154

N/A

0DataRank · unranked

23 citations

Keith T. Schmidt, Cindy H. Chau, William D. Figg, David Doan

Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p

Scientific Reports(2021)10.1038/s41598-021-90143-4

N/A

0DataRank · unranked

23 citations

Edel M. McCrea, Kristi Y. Lee, Jonathan D. Strope, Emily N. Risdon, Douglas K. Price +3 more

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers

Scientific Reports(2021)10.1038/s41598-021-84960-w

N/A

0DataRank · unranked

3 citations

Barış Türkbey, Billel Gasmi, Keith T. Schmidt, Jonathan D. Strope, Cindy H. Chau +15 more

Functional Drug Screening in the Era of Precision Medicine

Frontiers in Medicine(2022)10.3389/fmed.2022.912641

N/A

0DataRank · unranked

33 citations

William D. Figg, Cindy H. Chau, Giulia C. Napoli

Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome

Cancer Biology & Therapy(2022)10.1080/15384047.2022.2033059

N/A

0DataRank · unranked

6 citations

Cindy H. Chau, Douglas K. Price, William D. Figg, Kristi Y. Lee

Single whole genome sequencing analysis blazes the trail for precision medicine

Cancer Biology & Therapy(2022)10.1080/15384047.2022.2033058

N/A

0DataRank · unranked

2 citations

Cindy H. Chau, William D. Figg, Giulia C. Napoli

Self-reactive, innate-like T cells enhance cytotoxicity and immunosurveillance

Trends in cancer(2022)10.1016/j.trecan.2022.05.003

N/A

0DataRank · unranked

1 citations

Cindy H. Chau, William D. Figg, Blaire E. Barton

Liquid biopsy epigenomic profiling for cancer subtyping

Nature Medicine(2023)10.1038/s41591-023-02605-z

N/A

0DataRank · unranked

121 citations

Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian +38 more

Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex

Nature Communications(2023)10.1038/s41467-023-39374-9

N/A

0DataRank · unranked

28 citations

Simone A. Baechler, Xiaohu Zhang, Suresh Kumar, Valentina M. Factor, Yasuhiro Arakawa +20 more

Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer

Journal of Racial and Ethnic Health Disparities(2023)10.1007/s40615-023-01534-4

N/A

0DataRank · unranked

7 citations

Erica L. Beatson, Seth M. Steinberg, Cindy H. Chau, Douglas K. Price, William D. Figg +1 more

Targeting the metastatic niche: Single-cell lineage tracing in prime time

iScience(2023)10.1016/j.isci.2023.106174

N/A

0DataRank · unranked

4 citations

Giulia C. Napoli, Cindy H. Chau, Douglas K. Price, William D. Figg, Elijah Richard Sommer

Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3

Journal of Cancer(2023)10.7150/jca.90836

N/A

0DataRank · unranked

2 citations

Erica L. Beatson, Martina A. Knechel, Elijah Richard Sommer, Giulia C. Napoli, Emily N. Risdon +7 more

Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health

The Lancet Oncology(2024)10.1016/s1470-2045(24)00348-6

N/A

0DataRank · unranked

6 citations

Erica L. Beatson, Annieka Reno, Cindy H. Chau, Rosemarie Aurigemma, Patricia S. Steeg +2 more

Genomic Characterization of Preclinical Prostate Cancer Cell Line Models

International Journal of Molecular Sciences(2024)10.3390/ijms25116111

N/A

0DataRank · unranked

4 citations

Emily N. Risdon, Giulia C. Napoli, Douglas K. Price, Cindy H. Chau, William D. Figg +1 more

Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple Myeloma

Biomolecules(2024)10.3390/biom14060725

N/A

0DataRank · unranked

3 citations

Matthew K. Collins, Cindy H. Chau, Hyoyoung Choo‐Wosoba, David Venzon, Christian Steinebach +6 more

Revisiting the antiangiogenic mechanisms of fluorinated thalidomide derivatives

Bioorganic & Medicinal Chemistry Letters(2024)10.1016/j.bmcl.2024.129858

N/A

0DataRank · unranked

4 citations

Rabea Voget, Feiteng Lu, Kathleen M. Garchitorena, Yuen Lam Dora Ng, Cindy H. Chau +5 more

New Discorhabdin D Analogues from Latrunculia spp. Sponges

Journal of Natural Products(2024)10.1021/acs.jnatprod.4c01036

N/A

0DataRank · unranked

2 citations

Masoumeh Dalilian, Lin Du, Cindy H. Chau, William D. Figg, Barry R. O’Keefe +2 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5

N/A

0DataRank · unranked

6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more

Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7–Expressing CRPC Models

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0096

N/A

0DataRank · unranked

4 citations

Andres F. Leon, Erica L. Beatson, Jessica D. Kindrick, Kinjal Bhadresha, Xiaohu Zhang +15 more

Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activities

Biochemical and Biophysical Research Communications(2025)10.1016/j.bbrc.2025.152428

N/A

0DataRank · unranked

2 citations

Kathleen M. Garchitorena, David Tweedie, Cindy H. Chau, Chirag Patel, Maxime A. Siegler +7 more

Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profiling

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.31.673338

N/A

0DataRank · unranked

1 citations

Karl Semaan, Jiao Li, Ananthan Sadagopan, John Canniff, Noa Phillips +27 more

COVID‐19 Clinical Diagnostics and Testing Technology

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2020)10.1002/phar.2439

N/A

0DataRank · unranked

146 citations

Jonathan D. Strope, William D. Figg, Cindy H. Chau

Vaping and Cancer Metastasis: Novel Preclinical Insights and Results from the All of Us Research Program

The Oncologist(2025)10.1093/oncolo/oyaf190

N/A

0DataRank · unranked

0 citations

Cindy H. Chau, Douglas K. Price, William D. Figg, Dhruv G Pillai

PARP Inhibitors and Prostate Cancer: To Infinity and BeyondBRCA

The Oncologist(2020)10.1634/theoncologist.2020-0697

N/A

0DataRank · unranked

97 citations

Cindy H. Chau, Douglas K. Price, Oliver Sartor, William D. Figg, Emily N. Risdon